It's time
- PMID: 16370065
- PMCID: PMC2751267
- DOI: 10.1208/aapsj070365
It's time
Abstract
Statistical inference involves taking the results of models and knowledge about probability to make decisions about the relationship in question. This commentary explains the usefulness of statistical inference to the drug development process, as well as some common pitfalls. It also examines reasons why statistical inference does not seem to be fully integrated into pharmacometric modeling. An example is shown that demonstrates the inferential advantages of mechanistic models. Both statisticians and pharmacometricians ought to take note of these advantages and integrate their efforts in order to maximize the decision-making potential of clinical research.
References
-
- Salsburg D. The Lady Tasting Tea: How Statistics Revolutionized Science in the Twentieth Century. New York: Henry Holt and Company; 2002.
-
- Matthey S. p<05—But is it clinically significant? Practical examples for clinicians. Behav Change. 1998;15:140–146.
-
- Dixon P. The p-value fallacy and how to avoid it. Can J Exp Psychol. 2003;57:189–202. - PubMed
-
- Moye LA. Multiple Analyses in Clinical Trials. New York: Springer-Verlag; 2003.
-
- O’Hagan A, Luce BR. A Primer on Bayesian Statistics in Health Economics and Outcomes Research. Sheffield: Centre for Bayesian Statistics in Health Economics; 2003.
MeSH terms
LinkOut - more resources
Full Text Sources